Lineage Cell Therapeutics, Inc. Public Market Comparables
Find the most relevant public market comparables for Lineage Cell Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
A clinical-stage biotechnology company developing allogeneic, or “off the shelf”, cell therapies for serious neurological and ophthalmic conditions. The company develops and manufactures specialized human cells to replace or support dysfunctional or absent cells due to degenerative disease or traumatic injury.
Business Model
Developing and commercializing novel cell therapies for unmet medical needs, focusing on allogeneic (off-the-shelf) cell therapies for neurological and ophthalmic conditions.
Target Customers
Patients with serious neurological and ophthalmic conditions requiring cell therapy.
Specific Focus
Allogeneic cell therapies for neurological and ophthalmic conditions
Location
Carlsbad, California
CEO
Brian Culley
Industry
Life sciences
Sub Sector
Regenerative Medicine
3yr Revenue Growth
390%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Lineage Cell Therapeutics, Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Lineage Cell Therapeutics, Inc.? Our platform provides detailed analysis of Lineage Cell Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Lineage Cell Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Lineage Cell Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Lineage Cell Therapeutics, Inc. operates in the specialized Regenerative Medicine sub-sector. Understanding how Lineage Cell Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Regenerative Medicine space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Harmony Biosciences Holdings, Inc.
Pharmaceuticals • Life sciences
A commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company is dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs.
Molecular Templates, Inc.
Biotechnology • Life sciences
A clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells using a proprietary drug platform technology, Engineered Toxin Bodies (ETBs), to create novel therapies with potent and differentiated mechanisms of action for cancer and various disease indications. The company is no longer operating.
Alector Inc.
Healthcare • Life sciences
Alector Inc. is a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases, such as frontotemporal dementia, Alzheimer's disease, Parkinson's disease, and Lewy body dementia. The company leverages genetics, immunology, and neuroscience to advance a portfolio of genetically-validated programs aimed at removing toxic proteins, replacing deficient proteins, and restoring immune and nerve cell function.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Lineage Cell Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free